Cardiovascular Problems

The first afternoon session dives deep into some of neonatology's most enduring debates: managing the PDA and navigating the extreme pharmacological complexities of vasoactive drugs in premature infants. Here is a breakdown of the core messages from each speaker: Pharmacological Management of PDA (Gilles Cambonie) The debate over managing presymptomatic PDAs in extreme preterms continues. Prophylactic or early routine pharmacological treatment (within the first two weeks) is generally not recommended, as studies show it does not improve long-term outcomes (mortality or severe neurodevelopmental disability) and may increase risks of adverse events like severe BPD or infect…

NeoBP.com.br – Neonatal Blood Pressure Percentile Charts Hi, everyone! I'm a neonatologist from Brazil, and I'd like to share a project I've developed to make neonatal blood pressure assessment easier in everyday clinical practice. NeoBP is a free online tool that allows clinicians to consult neonatal blood pressure percentiles based on gestational age at birth and corrected gestational age. The charts are based on a study published by Hillman and colleagues in Neonatology in 2025: Oscillatory Blood Pressure Values in Newborn Infants: Observational Data Over Gestational Ages. This large observational study analyzed more than 1.4 million blood pressure measurements from 29…

You are invited to take part in a research study examining the use of acute inhaled nitric oxide (iNO) treatment for extremely preterm infants in neonatal intensive care units. We are conducting this study because the use of iNO in extremely preterm infants remains an area of clinical uncertainty, and practice may vary between clinicians and centres. The survey aims to describe current practice, understand factors influencing clinical decision-making, and identify areas where further research or guidance may be needed. You have been invited because you are a neonatal clinician involved in the care of extremely preterm infants. Your responses will help inform future rese…

Hello everyone! I'd love to hear your thoughts on the management of hemodynamically significant patent ductus arteriosus (PDA). This new article and its recommendations have left me with many questions. before the releae of these news recommendation , in our service, we only treat hemodynamically significant PDA within the first 7 days of life, primarily in patients under 28 weeks' gestational age. We know that the efficacy of medical treatment drops significantly after this age. Our approach is to opt for surgery only if the PDA doesn't close after two series of medical treatment, and we try not to delay the surgical intervention too much. I'm very interested in learnin…

There is a growing body of data suggesting that pulse oximetry before discharge from maternity wards can identify complex but yet asymptomatic cardiac malformations. It would be interesting to hear how common such screening has become. Please comment below too! The poll is open until 31 Jan 2012.

Hi, A case of ex micropremmie with IUGR who has severe PPHN and BPD. Following a severe PPHN crisis experts suggested trial of Bosentan in additional to the sildenafil already started. further course of oral steroids also started. Worked well and weaned ventilation over two weeks. I have minimal experience with Bosentan and wondered how much it is being used as an adjunct? Recognising used as a second line agent when things are in extremis. (no response to iNO). Questions such as typical length of courses being used? Successes? issues? no hepatic impairment at present. Thanks!

Dear Respected Colleagues: Greetings. I would like to know your opinion about using “Ibuprofen as prophylaxis for PDA in preterm babies”. Thanks.

I just wanted to share a link about inotropes, a blog post on a British FOAMed* web site: https://www.paediatricfoam.com/2017/01/inotropes-made-simple/ Managing circulatory failure with potent cardio- and vasoactive drugs can be a challenge, and it is necessary to understand the pathophysiology of the problem to choose the right set of interventions and drugs. *FOAMed = Free Open Access Medical Education

POCUSNEO Canada is pleased to announce the first e-workshops in advanced hemodynamics starting from 1️⃣5️⃣ August 2️⃣0️⃣2️⃣0️⃣ https://pocusneo.org/e-workshops/ https://pocusneo.org/e-conferences/ Yasser Elsayed (University of Manitoba) Muzafar Gani (McMaster University) Emailing E-conference Flyer final R.pdf

Dear doctors I need help in providing me with percentile charts for blood pressure readings in neonates preterms and full term ...i need to judge baby is hypertensive or not Thanks in advance 😊